Craig R. Salhoff

Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740):  A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties

James A. Monn, Matthew J. Valli, Steven M. Massey et al. · Journal of Medicinal Chemistry · 1997 · 393 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

3,5‐Dihydroxyphenylglycine Is a Highly Selective Agonist for Phosphoinositide‐Linked Metabotropic Glutamate Receptors in the Rat Hippocampus

Darryle D. Schoepp, John Goldsworthy, Bryan G. Johnson et al. · Journal of Neurochemistry · 1994 · 269 citations

Life Sciences, Neuroscience, Pharmacology +17

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

Eleni T. Tzavara, Richard J. Davis, Kenneth W. Perry et al. · British Journal of Pharmacology · 2003 · 269 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

LY354740 is a Potent and Highly Selective Group II Metabotropic Glutamate Receptor Agonist in Cells Expressing Human Glutamate Receptors

Darryle D. Schoepp, Bryan G. Johnson, Rebecca A. Wright et al. · Neuropharmacology · 1997 · 227 citations

Life Sciences, Neuroscience, Pharmacology +11

In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders

Linda M. Rorick‐Kehn, Bryan G. Johnson, Karen M. Knitowski et al. · Psychopharmacology · 2007 · 157 citations

Medicine, Pharmacology, Psychiatry +8